The National Institute on Drug Abuse (NIDA) announced today the launch of its Addiction Performance Project (http://www.drugabuse.gov/nidamed/APP/), an innovative continued medical education program designed to help primary care providers break down the stigma associated with addiction. The program includes dramatic interpretation of a family’s struggle with addiction, followed by a dialogue among participants aimed to foster compassion, cooperation, and understanding for patients living with this disease.
Of the 23.5 million patients who needed specialized treatment for a drug or alcohol problem in 2009, nearly 90 percent had not received it. Research suggests that primary care providers could significantly help reduce drug use, before it escalates to abuse or addiction. However, many express concern that they do not have the experience or tools to identify drug use in their patients.
“Primary care providers can play such a vital role in screening for drug abuse, said NIDA Director Dr. Nora D. Volkow. “Yet, for many providers, discussing drug abuse with their patients is beyond their comfort zone. NIDA’s Addiction Performance Project is a creative way for doctors to earn CME credit while breaking down the stigma associated with drug addiction.”
Each performance begins with a dramatic reading of Act III of Eugene O’Neill’s Long Day’s Journey into Night.
The Washington, D.C., launch performance took place this past Saturday, featuring Blythe Danner reading the part of Mary Tyrone, the morphine-addicted matriarch of a family devastated by addiction, and Harris Yulin as James Tyrone, Mary’s husband.
Readings are followed by an expert panel reaction and facilitated audience discussion that fosters compassion, cooperation, and understanding for addicted patients and their families. Expert panelists for the D.C. performance included NIDA Director Nora D. Volkow, M.D., Jeffrey Baxter, M.D., of the University of Massachusetts Medical School and Dr. Robert Taylor, M.D., the dean of Howard University Medical School, Washington, D.C.
Addiction Performance Project is part of NIDAMED (http://drugabuse.gov/nidamed/), NIDA’s outreach to practicing physicians, physicians in training, and other health professionals. It has a limited run during 2011 and 2012, with the next scheduled performance in Phoenix, Ariz. on May 6.
Performances are free, but seating is limited, and registration is recommended. Attendees do not have to be registrants at the conferences where some performances take place. For more information on the Addiction Performance Project, or to register for a performance, visit: http://www.drugabuse.gov/nidamed/APP.
The National Institute on Drug Abuse is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world’s research on the health aspects of drug abuse and addiction. The Institute carries out a large variety of programs to inform policy and improve practice. Fact sheets on the health effects of drugs of abuse and information on NIDA research and other activities can be found on the NIDA home page at www.drugabuse.gov. To order publications in English or Spanish, call NIDA’s new DrugPubs research dissemination center at 1-877-NIDA-NIH or 240-645-0228 (TDD) or fax or email requests to 240-645-0227 or firstname.lastname@example.org. Online ordering is available at http://drugpubs.drugabuse.gov. NIDA’s new media guide can be found at http://drugabuse.gov/mediaguide/.
About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
NIDA Press Office